Citadel Advisors’s Rocket Pharmaceuticals, Inc. Warrant RCKTW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.07K | Sell |
314,842
-2,461
| -0.8% | -$71 | ﹤0.01% | 5682 |
|
|
2025
Q1 | $14.9K | Sell |
317,303
-20,301
| -6% | -$954 | ﹤0.01% | 5644 |
|
|
2024
Q4 | $11.6K | Sell |
337,604
-5,793
| -2% | -$199 | ﹤0.01% | 5711 |
|
|
2024
Q3 | $24K | Sell |
343,397
-27,202
| -7% | -$1.9K | ﹤0.01% | 5308 |
|
|
2024
Q2 | $22.3K | Buy |
370,599
+5,776
| +2% | +$348 | ﹤0.01% | 5377 |
|
|
2024
Q1 | $109K | Buy |
364,823
+64,523
| +21% | +$19.3K | ﹤0.01% | 5045 |
|
|
2023
Q4 | $147K | Sell |
300,300
-24,549
| -8% | -$12K | ﹤0.01% | 4743 |
|
|
2023
Q3 | $49.6K | Sell |
324,849
-27,965
| -8% | -$4.27K | ﹤0.01% | 5083 |
|
|
2023
Q2 | $65.4K | Sell |
352,814
-4,636
| -1% | -$860 | ﹤0.01% | 4902 |
|
|
2023
Q1 | $58.4K | Buy |
+357,450
| New | +$58.4K | ﹤0.01% | 5105 |
|